摘要
目的:观察匹多莫德联合干扰素治疗小儿反复呼吸道感染(RRTI)的临床疗效。方法:对照组采用常规治疗,治疗组在常规基础上给予干扰素雾化吸入和匹多莫德口服治疗,观察比较两组的总有效率、症状、体征及免疫学检查结果。结果:治疗组总有效率为86.0%,对照组总有效率为28.0%,两组比较P<0.05;治疗组发热、扁桃体肿大、肺内罗音的消退时间短于对照组;T细胞亚群CD4+较对照组升高,CD8+较对照组降低。结论:干扰素雾化吸入联合匹多莫德治疗RRTI有较好的临床疗效。
Objective：To observe the treatment effects of Pidotomod combined with interferon on children＇s recurrent respiratory infection.Methods：100 children with recurrent respiratory infection were divided into control group and treatment group randomly.The conventional therapy was used in control group;on a regular basis,the interferon atomization and oral Pidotimod were used in treatment group.The total effective rates of the two groups were observed.Results：The total efficiency was 88.6% in the treatment group and 28.0% in the control group,the difference was statistically significant,P0.05;And the subsided time of the fever,swollen tonsils,and roles in pulmonary in the treatment group were shorter than the control group;The level of CD4＋ in treatment group was higher than the control group,the level of CD8＋ in treatment group was lower than the control group.Conclusion：There is significant effects of Pidotomod on children＇s recurrent respiratory infection.
出处
《中国妇幼保健》
CAS
北大核心
2012年第5期696-697,共2页
Maternal and Child Health Care of China
基金
河北省唐山市科技局科技攻关项目〔06134618e〕
关键词
匹多莫德
干扰素
反复呼吸道感染
防治
Pidotomod
Interferon
Recurrent respiratory infection
Prevention and cure
